This book, now in a revised third edition, provides practical guidance on the use of radiotherapy techniques in the management of benign diseases. In this edition, the content is grouped in chapters according to the disease category, including autoimmune disorders, dermatologic conditions, infectious diseases, inflammatory diseases, endocrinological disorders, musculoskeletal disorders, neurological disorders, benign lymphoid disorders, pain disorders, psychiatric disorders, reproductive topics, benign tumors/pre-malignant conditions, and vascular disorders. The format of the different…mehr
This book, now in a revised third edition, provides practical guidance on the use of radiotherapy techniques in the management of benign diseases.
In this edition, the content is grouped in chapters according to the disease category, including autoimmune disorders, dermatologic conditions, infectious diseases, inflammatory diseases, endocrinological disorders, musculoskeletal disorders, neurological disorders, benign lymphoid disorders, pain disorders, psychiatric disorders, reproductive topics, benign tumors/pre-malignant conditions, and vascular disorders. The format of the different sub-chapters follows those of the previous editions: Each of the sub-chapters features a brief summary, followed by explanatory tables and reference lists.
This concise yet comprehensive book is an invaluable resource for radiation oncologists.
David Roberge, MD completed medical school at the University of Montreal (1997) before completing a residency at McGill University (2002) and fellowships at St-Jude Children's Research Hospital (2002) and Stanford University (2003). He has authored over one hundred fifty peer-reviewed articles (H-index 43) and other scholarly works. He has a broad interest and expertise in radiation oncology (including radiotherapy of benign disease) but is best known for his work in the field of brain tumors. He is currently president elect of the Canadian Association of Radiation Oncology and a Full Professor of Radiology, Radiation Oncology and Nuclear Medicine at the University of Montreal. Sarah S. Donaldson, MD completed medical school at Harvard (1968) before completing a residency at Stanford University (1972), an internship at the University of Washington (1969) and fellowships at both MD Anderson Cancer Center (1971) and Institut Gustave-Roussy (1973). She has authored several hundred peer-reviewed articles (H-index 79) and other publications. Her knowledge is broad, but she is best known for her work in the field of pediatric radiation oncology. She is the recipient of innumerable honors and awards, including: ASCO Pediatric Oncology Award, American Society of Clinical Oncology (2007) ASCO Statesman Award, American Society of Clinical Oncology (2007) Elizabeth Blackwell Award, American Medical Women's Association (2005) Fellow, American Society of Clinical Oncology (2012) Fellow, American Society of Therapeutic Radiology and Oncology (2006) Gold Medal, American College of Radiology (2007) Gold medal, American Society of Therapeutic Radiology and Oncology (2000) Gold Medal, Radiological Society of North America (2018) The Dean's Medal, Stanford University School of Medicine (2012) Women Who Conquer Cancer Mentorship Award, Conquer Cancer Foundation of ASCO (2016)
Inhaltsangabe
Estimating the Risk of Radiation-Induced Malignancy Following Radiotherapy for Benign Disease.- Understanding Radiation Units.- Autoimmune Disorders.- Dermatologic Conditions.- Infectious Disease.- Diseases of Inflammation.- Endocrinological Disorders.- Musculoskeletal Disorders.- Neurological Disorders.- Benign Lymphoid Disorders.- Pain Disorders.- Psychiatric Disorders.- Reproduction.- Benign Tumors/Premalignant Conditions.- Vascular Disorders.- Other.
